Sixten Borg

1.7k total citations
43 papers, 1.3k citations indexed

About

Sixten Borg is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Sixten Borg has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Physiology. Recurrent topics in Sixten Borg's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Asthma and respiratory diseases (8 papers). Sixten Borg is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Asthma and respiratory diseases (8 papers). Sixten Borg collaborates with scholars based in Sweden, United Kingdom and United States. Sixten Borg's co-authors include Fredrik Andersson, Bo Lundbäck, Sven‐Arne Jansson, Lene Riis, Tine Jess, Pia Munkholm, Ebbe Langholz, Ida Vind, Karen V. Winther and Vibeke Binder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Sixten Borg

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sixten Borg Sweden	18	609	389	300	295	164	43	1.3k
Douglas L. Nguyen United States	22	262 0.4×	445 1.1×	157 0.5×	402 1.4×	70 0.4×	72	1.4k
Luis Cea‐Calvo Spain	23	136 0.2×	268 0.7×	102 0.3×	172 0.6×	96 0.6×	112	1.4k
Mark Nuijten Netherlands	22	349 0.6×	280 0.7×	387 1.3×	56 0.2×	252 1.5×	72	1.5k
Anna O. D’Souza United States	16	463 0.8×	225 0.6×	246 0.8×	34 0.1×	70 0.4×	32	962
Ajitha Mannalithara United States	24	535 0.9×	610 1.6×	150 0.5×	55 0.2×	50 0.3×	68	2.1k
Wendy Metcalfe United Kingdom	25	277 0.5×	186 0.5×	57 0.2×	219 0.7×	113 0.7×	56	1.9k
Eric Esrailian United States	25	136 0.2×	641 1.6×	97 0.3×	299 1.0×	176 1.1×	54	1.6k
I T Russell United Kingdom	17	448 0.7×	64 0.2×	86 0.3×	101 0.3×	94 0.6×	31	1.3k
Sudeep Karve United States	20	154 0.3×	321 0.8×	44 0.1×	99 0.3×	243 1.5×	63	1.5k
Nikola Kocev Serbia	20	119 0.2×	124 0.3×	82 0.3×	120 0.4×	57 0.3×	58	1.1k

Countries citing papers authored by Sixten Borg

Since Specialization

Citations

This map shows the geographic impact of Sixten Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixten Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixten Borg more than expected).

Fields of papers citing papers by Sixten Borg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixten Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixten Borg. The network helps show where Sixten Borg may publish in the future.

Co-authorship network of co-authors of Sixten Borg

This figure shows the co-authorship network connecting the top 25 collaborators of Sixten Borg. A scholar is included among the top collaborators of Sixten Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixten Borg. Sixten Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borg, Sixten, et al.. (2023). Implementation of the measure of case discussion complexity to guide selection of prostate cancer patients for multidisciplinary team meetings. Cancer Medicine. 12(14). 15149–15158. 3 indexed citations

Leksell, Janeth, Unn‐Britt Johansson, Sixten Borg, et al.. (2020). New Diabetes Questionnaire to add patients’ perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables. BMJ Open. 10(11). e038966–e038966. 5 indexed citations

Borg, Sixten, et al.. (2019). Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden. BMJ Open. 9(1). e025033–e025033. 23 indexed citations

Leksell, Janeth, Unn‐Britt Johansson, Sixten Borg, et al.. (2019). Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes – a nationwide cross-sectional study. Health and Quality of Life Outcomes. 17(1). 141–141. 43 indexed citations

Borg, Sixten, Ulf‐G. Gerdtham, Katarina Eeg‐Olofsson, Bo Palaszewski, & Soffia Guðbjörnsdóttir. (2019). Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes. Health Economics Review. 9(1). 31–31. 6 indexed citations

Hoogendoorn, Martine, Talitha Feenstra, Melinde Boland, et al.. (2017). Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. International Journal of COPD. Volume 12. 3183–3194. 33 indexed citations

Leksell, Janeth, Unn‐Britt Johansson, Katarina Eeg‐Olofsson, et al.. (2017). A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability. Patient Education and Counseling. 101(1). 139–146. 29 indexed citations

Hoogendoorn, Martine, Talitha Feenstra, Yumi Asukai, et al.. (2016). Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?. Value in Health. 19(6). 800–810. 10 indexed citations

Hoogendoorn, Martine, Talitha Feenstra, Yumi Asukai, et al.. (2015). Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd): are Current Models Suitable to Evaluate Personalized Medicine. Value in Health. 18(7). A694–A694. 2 indexed citations

10.

Hofmarcher, Thomas & Sixten Borg. (2015). Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden. Journal of Medical Economics. 18(7). 492–501. 21 indexed citations

11.

Lökk, Johan, et al.. (2011). Drug and treatment costs in Parkinson’s disease patients in Sweden. Acta Neurologica Scandinavica. 125(2). 142–147. 32 indexed citations

12.

Borg, Sixten, Anna Glenngård, Anders Österborg, & Ulf Persson. (2008). The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: A Markov model. Acta Oncologica. 47(6). 1009–1017. 9 indexed citations

13.

Ödegaard, Knut, et al.. (2008). The Swedish cost burden of overweight and obesity – evaluated with the PAR approach and a statistical modelling approach. International Journal of Pediatric Obesity. 3(s1). 51–57. 20 indexed citations

14.

Tunsäter, Alf, et al.. (2006). Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden. Health Policy. 81(2-3). 309–319. 3 indexed citations

15.

Borg, Sixten, et al.. (2006). Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-Receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: A decision-analytic model. Clinical Therapeutics. 28(11). 1947–1959. 7 indexed citations

16.

Persson, Ulf, Sixten Borg, Tor Ekman, et al.. (2005). Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response. Advances in Therapy. 22(3). 208–224. 12 indexed citations

17.

Ericsson, Karin, Theo A. Bantje, Rudolf M. Huber, Sixten Borg, & Eric D. Bateman. (2005). Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma. Respiratory Medicine. 100(4). 586–594. 12 indexed citations

18.

Jansson, Sven‐Arne, Anne Lindberg, Sixten Borg, et al.. (2005). Cost Differences for COPD With and Without Physician-Diagnosis. COPD Journal of Chronic Obstructive Pulmonary Disease. 2(4). 427–434. 16 indexed citations

19.

Borg, Sixten, et al.. (2005). Obesity, Survival, and Hospital Costs—Findings from a Screening Project in Sweden. Value in Health. 8(5). 562–571. 49 indexed citations

20.

Andersson, Fredrik, Sixten Borg, & Elisabeth Ståhl. (2003). The Impact of Exacerbations on the Asthmatic Patient's Preference Scores. Journal of Asthma. 40(6). 615–623. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact